![](https://h2i.utoronto.ca/wp-content/uploads/sites/2/2022/02/QQlDND6T_400x400.jpeg)
GoodCap Pharmaceuticals
GoodCap is the only drug development company developing low-dose, sub-hallucinogenic psilocybin-based therapies to treat mood disorders by targeting low-grade inflammation in the gut.CONTACT: info@goodcap.com
GoodCap is the only drug development company developing low-dose, sub-hallucinogenic psilocybin-based therapies to treat mood disorders by targeting low-grade inflammation in the gut.CONTACT: info@goodcap.com